These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11425584)

  • 1. Synthesis and properties of bile acid phosphoramidites 5'-tethered to antisense oligodeoxynucleotides against HCV.
    Lehmann TJ; Engels JW
    Bioorg Med Chem; 2001 Jul; 9(7):1827-35. PubMed ID: 11425584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and properties of hepatitis C virus antisense oligonucleotides for liver specific drug targeting.
    Lehmann TJ; Serwe M; Caselmann WH; Engels JW
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1343-6. PubMed ID: 11563018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
    González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
    Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of conjugates of oligodeoxynucleotides and lipid structures and their interaction with low-density lipoprotein.
    Rump ET; de Vrueh RL; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
    Bioconjug Chem; 1998; 9(3):341-9. PubMed ID: 9576808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides.
    Lischka K; Starke D; Failing K; Herling A; Kramer W; Petzinger E
    Biochem Pharmacol; 2003 Aug; 66(4):565-77. PubMed ID: 12906921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic studies on hairpin forming antisense-oligodeoxynucleotides directed against hepatitis C virus RNA.
    Lehmann TJ; Eisenhardt S; Engels JW
    Nucleosides Nucleotides; 1999; 18(6-7):1689-91. PubMed ID: 10474247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.
    Alt M; Eisenhardt S; Serwe M; Renz R; Engels JW; Caselmann WH
    Eur J Clin Invest; 1999 Oct; 29(10):868-76. PubMed ID: 10583429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic nucleosides and nucleotides. 37. Antisense oligodeoxynucleotides bearing 5-(phenylethyl)-2'-deoxyuridylate at the 3'-terminus: exonuclease-resistant molecule with natural phosphodiester backbone.
    Kawaguchi T; Yamaguchi T; Tanaka S; Tashiro Y; Saneyoshi M
    J Pharm Sci; 1996 Aug; 85(8):815-8. PubMed ID: 8863269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.
    Mier W; Eritja R; Mohammed A; Haberkorn U; Eisenhut M
    Bioconjug Chem; 2000; 11(6):855-60. PubMed ID: 11087334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.
    Vidalin O; Major ME; Rayner B; Imbach JL; Trépo C; Inchauspé G
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2337-44. PubMed ID: 8891141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
    Seki M; Honda Y
    J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.
    Caselmann WH; Eisenhardt S; Alt M
    Intervirology; 1997; 40(5-6):394-9. PubMed ID: 9675643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines.
    Sanghvi YS; Hoke GD; Freier SM; Zounes MC; Gonzalez C; Cummins L; Sasmor H; Cook PD
    Nucleic Acids Res; 1993 Jul; 21(14):3197-203. PubMed ID: 8393563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4'-C-(Aminoethyl)thymidine and 4'-C-[(N-Methyl)aminoethyl] Thymidine Nucleosides to Enhance DNA Stability.
    Chandela A; Ueda H; Ueno Y
    Curr Protoc; 2022 Sep; 2(9):e501. PubMed ID: 36073858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
    Lavigne C; Yelle J; Sauvé G; Thierry AG
    AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 5-Cyanomethyluridine (cnm
    Mao S; Tsai HC; Sheng J
    Curr Protoc Nucleic Acid Chem; 2020 Sep; 82(1):e114. PubMed ID: 32846053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-functionalized locked nucleic acids: oligonucleotides with extraordinary binding affinity, target specificity, and enzymatic stability.
    Kaura M; Guenther DC; Hrdlicka PJ
    Org Lett; 2014 Jun; 16(12):3308-11. PubMed ID: 24890872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis of 5'-triantennary N-acetylgalactosamine conjugated antisense oligonucleotides using phosphoramidite chemistry.
    Prakash TP; Brad Wan W; Low A; Yu J; Chappell AE; Gaus H; Kinberger GA; Østergaard ME; Migawa MT; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4127-30. PubMed ID: 26299345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active oligodeoxyribonucleotides--I: Syntheses and anti-HIV-1 activities of 5'-modified pentadecadeoxyribonucleotides.
    Hotoda H; Momota K; Furukawa H; Nakamura T; Kaneko M; Kimura S; Shimada K
    Nucleic Acids Symp Ser; 1993; (29):59-61. PubMed ID: 8247795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.